Suchergebnisse - "Kabamba-Mukadi, Benoît"

PubPharm (23)

1

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

enthalten in: BMC infectious diseases | 2019

von Goletti, S. | Zuyten, S. | Goeminne, L. | +6

2

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

enthalten in: BMC infectious diseases | 2019

von Goletti, S. | Zuyten, S. | Goeminne, L. | +6

3

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

enthalten in: BMC infectious diseases | 2019

von Goletti, S. | Zuyten, S. | Goeminne, L. | +6

4

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population : the experience of Belgium

enthalten in: BMC public health | 2019

von Lernout, T. | Kabamba-Mukadi, B. | Saegeman, V. | +6

5

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

enthalten in: BMC public health | 2019

von Lernout, T. | Kabamba-Mukadi, B. | Saegeman, V. | +6

6

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

enthalten in: BMC public health | 2019

von Lernout, T. | Kabamba-Mukadi, B. | Saegeman, V. | +6

7

Short Communication : An Insertion of Seven Amino Acids in the Envelope Cytoplasmic Tail of HIV-2 Selected During Disease Progression Enhances Viral Replication

enthalten in: AIDS research and human retroviruses | 2019

von Dufrasne, F. | Lucchetti, M. | Dessilly, G. | +3

8

Low hepatitis C prevalence in Belgium : implications for treatment reimbursement and scale up

enthalten in: BMC public health | 2019

von Litzroth, A. | Suin, V. | Wyndham-Thomas, C. | +8

9

Performance Evaluation of the MBT STAR®-Carba IVD Assay for the Detection of Carbapenemases With MALDI-TOF MS

enthalten in: Frontiers in microbiology | 2019

von Anantharajah, A. | Tossens, B. | Olive, N. | +3

10

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

enthalten in: BMC public health | 2019

von Litzroth, A. | Suin, V. | Wyndham-Thomas, C. | +8